Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kufa

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Medicinal Chemistry|December 2, 2022
Pyrimidine derivatives with antitubercular activityVladimir Finger, Martin Kufa, Ondrej Soukup, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizonMartin Kufa, Vladimir Finger, Ondrej Kovar, et al.
Journal of Medicinal Chemistry|October 7, 2025
Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case StudiesOndrej Kovar, Martin Kufa, Vladimir Finger, et al.
European Journal of Medicinal Chemistry|December 24, 2025
Novel pyrimidine derivatives as promising antimycobacterial agentsMartin Kufa, Vladimir Finger, Ondrej Kovar, et al.
European Journal of Medicinal Chemistry|March 30, 2023
Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids - Design, synthesis, and biological evaluationFilip Pidany, Jana Kroustkova, Abdullah Al Mamun, et al.
European Journal of Medicinal Chemistry|July 8, 2023
2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1Vladimir Finger, Tomas Kucera, Radka Kafkova, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 13, 2025
Novel antitubercular agents based on 2,4-disubstituted 5-(aryl-2-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidinesVladimir Finger, Martin Vrbicky, Lubica Muckova, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Medicinal Chemistry|December 2, 2022
Pyrimidine derivatives with antitubercular activityVladimir Finger, Martin Kufa, Ondrej Soukup, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizonMartin Kufa, Vladimir Finger, Ondrej Kovar, et al.
Journal of Medicinal Chemistry|October 7, 2025
Scaffold Hopping in Tuberculosis Drug Discovery: Principles, Applications, and Case StudiesOndrej Kovar, Martin Kufa, Vladimir Finger, et al.
European Journal of Medicinal Chemistry|December 24, 2025
Novel pyrimidine derivatives as promising antimycobacterial agentsMartin Kufa, Vladimir Finger, Ondrej Kovar, et al.
European Journal of Medicinal Chemistry|March 30, 2023
Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids - Design, synthesis, and biological evaluationFilip Pidany, Jana Kroustkova, Abdullah Al Mamun, et al.
European Journal of Medicinal Chemistry|July 8, 2023
2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1Vladimir Finger, Tomas Kucera, Radka Kafkova, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 13, 2025
Novel antitubercular agents based on 2,4-disubstituted 5-(aryl-2-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidinesVladimir Finger, Martin Vrbicky, Lubica Muckova, et al.
Pageof 1